Evidence that reduced lipoprotein lipase activity is not a primary pathogenetic factor for hypertriglyceridemia in renal failure
- 1 September 1995
- journal article
- Published by Elsevier in Kidney International
- Vol. 48 (3) , 779-784
- https://doi.org/10.1038/ki.1995.350
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failureKidney International, 1992
- Lipid and Apolipoprotein Profiles of Uremic Dyslipoproteinemia -Relation to Renal Function and DialysisNephron, 1991
- Anomalies in composition of uremic lipoproteins isolated by gradient ultracentrifugation: relative enrichment of HDL in apolipoprotein C-III at the expense of apolipoprotein A-IAtherosclerosis, 1988
- Pathogenic roles of post-heparin lipases in lipid abnormalities in hemodialysis patientsKidney International, 1984
- Analysis of cardiovascular risk factors in chronic hemodialysis patients with special attention to the hyperlipoproteinemiasAtherosclerosis, 1983
- Postheparin plasma triglyceride lipases in chronic hemodialysis: Evidence for a role for hepatic lipase in lipoprotein metabolismMetabolism, 1979
- Heparin-Released Plasma Lipases in Chronic Renal Failure and after Renal TransplantationClinical Science, 1979
- Selective Deficiency of Hepatic Triglyceride Lipase in Uremic PatientsNew England Journal of Medicine, 1977
- Prevalence of serum lipid abnormalities in chronic hemodialysisMetabolism, 1977
- HypertriglyceridemiaNew England Journal of Medicine, 1968